With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
DHS Leads Government’s Largest Civilian AI Hiring Effort
On this AI GovCast miniseries, Boyce discusses his journey to the agency with his prior roles at the Office of Management and Budget.
15m listen -
Storytelling Miniseries: Using Narratives to Nurture Relationships
In the final episode of our Storytelling Miniseries, we discuss building meaningful relationships through storytelling.
20m listen -
VHA Highlights Emerging Tech Impacts Over 2024
VHA's 2024 Innovation Report highlights the innovations enabling the agency to keep pace with the surge of claims and benefits delivery.
4m read -
How AI Improves Decision-Making and Workload at Borders
Customs and Border Protection CTO Sunil Madhugiri discussed how the agency is using artificial intelligence at the nation’s borders.
19m listen
